Successful topical application of Ankaferd blood stopper in a patient with life-threatening fundal variceal bleeding despite cyanoacrilate injection

Clin Res Hepatol Gastroenterol. 2012 Feb;36(1):e9-11. doi: 10.1016/j.clinre.2011.07.010. Epub 2011 Aug 24.

Abstract

Gastric variceal bleeding is a common problem in patients with cirrhosis and despite early endoscopic and/or pharmacological therapy, variceal bleeding cannot be controlled or recurs early in about 10 to 20% of patients with considerable morbidity and mortality rates. For this reason, effective control of active bleeding varices is of great importance for the prevention of late complications. Although endoscopic band ligation and sclerotherapy are the choice of endoscopic treatment modalities with various grades of success, limited data is available for the use of Ankaferd Blood Stopper (ABS) for the controlling of variceal bleeding due to gastric varices. We herein present a unique case of gastric variceal bleeding despite cyanoacrilate injection, which was successfully controlled with topical ABS application.

Publication types

  • Case Reports

MeSH terms

  • Administration, Mucosal
  • Cyanoacrylates / administration & dosage*
  • Esophageal and Gastric Varices / complications
  • Esophageal and Gastric Varices / drug therapy*
  • Female
  • Gastrointestinal Hemorrhage / drug therapy*
  • Gastrointestinal Hemorrhage / etiology
  • Gastroscopy*
  • Hemostatics / administration & dosage
  • Hemostatics / therapeutic use*
  • Humans
  • Injections, Intralesional
  • Liver Cirrhosis
  • Middle Aged
  • Plant Extracts / administration & dosage
  • Plant Extracts / therapeutic use*
  • Treatment Outcome

Substances

  • Cyanoacrylates
  • Hemostatics
  • Plant Extracts
  • ankaferd blood stopper